Peripheral metabolic abnormalities of lipids and amino acids implicated in increased risk of suicidal behavior in major depressive disorder

Metabolomics

Volumn 9, Issue 3, 2013, Pages 688-696

  Zheng, Peng ^a,c   Gao, Hong Chang ^b   Qi, Zhi Guo ^a,c   Jia, Jian Min ^b   Li, Fang Fang ^a,c   Chen, Jian Jun ^a,c   Wang, Ying ^a,c   Guo, Jing ^a,c   Melgiri, N D ^a,c   Xie, Peng ^a,c  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

^c CHONGQING KEY LABORATORY OF NEUROBIOLOGY   (China)

Author keywords

Major depressive disorder (MDD); Metabonomics; NMR; Predisposition; Suicide

Indexed keywords

ALANINE; CHOLESTEROL; GLUCOSE; GLYCINE; LACTIC ACID; LOW DENSITY LIPOPROTEIN; PYRUVIC ACID; TAURINE; UNSATURATED FATTY ACID; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AMINO ACID METABOLISM; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; METABOLIC DISORDER; METABOLITE; PATIENT CODING; PROTON NUCLEAR MAGNETIC RESONANCE; SUICIDAL BEHAVIOR;

EID: 84877635956     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-012-0474-9     Document Type: Article

References (23)

1. Barton, R. H., et al. (2010). The influence of EDTA and citrate anticoagulant addition to human plasma on information recovery from NMR-based metabolic profiling studies. Molecular Biosystems, 6(1), 215-224.
2. Blair-West, G. W., Cantor, C. H., Mellsop, G. W., & Eyeson-Annan, M. L. (1999). Lifetime suicide risk in major depression: Sex and age determinants. Journal of Affective Disorders, 55(2-3), 171-178.
3. Coen, M., Lenz, E. M., Nicholson, J. K., Wilson, I. D., Pognan, F., & Lindon, J. C. (2003). An integrated metabonomic investigation of acetaminophen toxicity in the mouse using NMR spectroscopy. Chemical Research in Toxicology, 16(3), 295-303.
4. Craig, A., Cloarec, O., Holmes, E., Nicholson, J. K., & Lindon, J. C. (2006). Scaling and normalization effects in NMR spectroscopic metabonomic data sets. Analytical Chemistry, 78(7), 2262-2267.
5. Elizabeth Sublette, M., et al. (2011). Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder. Brain, Behavior, and Immunity, 25(6), 1272-1278.
6. Gowda, G., Zhang, S., Gu, H., Asiago, V., Shanaiah, N., & Raftery, D. (2008). Metabolomics-based methods for early disease diagnostics. Expert Review of Molecular Diagnostics, 8(5), 617-633.
7. Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23(1), 56.
8. Holmes, E., et al. (2006). Metabolic profiling of CSF: Evidence that early intervention may impact on disease progression and outcome in schizophrenia. Plos Medicine, 3(8), 327.
9. 1H NMR-based metabolomics. Journal of Agricultural and Food Chemistry, 58(19), 10458-10466.
10. Kessler, R. C., Berglund, P., Borges, G., Nock, M., & Wang, P. S. (2005). Trends in suicide ideation, plans, gestures, and attempts in the United States, 1990-1992 to 2001-2003. JAMA, 293(20), 2487.
11. Kessler, R. C., et al. (2003). The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA, 289(23), 3095-3105.
12. Kim, Y. K., & Myint, A. M. (2004). Clinical application of low serum cholesterol as an indicator for suicide risk in major depression. Journal of Affective Disorders, 81(2), 161-166.
13. Lalovic, A., Klempan, T., Sequeira, A., Luheshi, G., & Turecki, G. (2010). Altered expression of lipid metabolism and immune response genes in the frontal cortex of suicide completers. Journal of Affective Disorders, 120(1-3), 24-31.
14. Lan, M., et al. (2008). Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder. Moleular Psychiatry, 14(3), 269-279.
15. Lee, S., et al. (2009). The epidemiology of depression in metropolitan China. Psychological Medicine, 39(5), 735-747.
16. Mann, J. J. (2003). Neurobiology of suicidal behaviour. Nature Reviews Neuroscience, 4(10), 819-828.
17. 1H-13C NMR spectroscopy of human blood plasma. Analytical Chemistry, 67(5), 793-811.
18. Nicholson, J. K., & Lindon, J. C. (2008). Systems biology: Metabonomics. Nature, 455(7216), 1054-1056.
19. Nicholson, J. K., Lindon, J. C., & Holmes, E. (1999). 'Metabonomics': Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica, 29(11), 1181-1189.
20. Sublette, M. E., Hibbeln, J. R., Galfalvy, H., Oquendo, M. A., & Mann, J. J. (2006). Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk. American Journal of Psychiatry, 163(6), 1100.
21. Trygg, J., & Wold, S. (2002). Orthogonal projections to latent structures (O-PLS). Journal of Chemometrics, 16(3), 119-128.
22. Tsang, T. M., Jeffrey, T. J. H., Holmes, E., & Bahn, S. (2006). Metabolic profiling of plasma from discordant schizophrenia twins: Correlation between lipid signals and global functioning in female schizophrenia patients. Journal of Proteome Research, 5(4), 756-760.
23. Zheng, P., et al. (2012). Plasma metabonomics as a novel diagnostic approach for major depressive disorder. Journal of Proteome Research, 11(3), 1741-1748.